← Back
$KURA All transactions

Kura Oncology, Inc.

A

$ Value

$0

Shares

182,500

Price

$0

Filed

Sep 29

Insider

Name

WILSON TROY EDWARD

Title

President and CEO

CIK

0001589597

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-27

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

283,468

Footnotes

Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.

Filing Info

Accession No.

0001193125-25-223663

Form Type

4

Issuer CIK

0001422143

WILSON TROY EDWARD's History

Date Ticker Type Value
2026-03-23 KURA M $38K
2026-03-23 KURA M $0
2026-01-02 KURA A $0
2025-11-13 KURA A $0
2025-09-29 KURA $327K
2025-09-27 KURA A $0
2025-09-08 KURA $410K
2025-09-05 RNA M $181K
2025-09-05 RNA $725K
2025-09-05 RNA $750K

Other Insiders at KURA (90d)

Insider Bought Sold Last
WILSON TROY EDWARD
President and CEO
2026-03-23
FORD KATHLEEN
Chief Operating Officer
$15K 2026-01-27
Bair Teresa Brophy
Chief Legal Officer
$95K 2026-01-27
DOYLE THOMAS JAMES
SVP, Finance & Accounting
$60K 2026-01-27
Powl Brian T.
Chief Commercial Officer
$54K 2026-01-27
Leoni Mollie
Chief Medical Officer
$69K 2026-01-27
Burrows Francis
Chief Scientific Officer
$11K 2026-01-27